Steroid myopathy in cancer patients

Neurology

Volumn 48, Issue 5, 1997, Pages 1234-1238

  Batchelor, T T ^a   Taylor, L P ^b   Thaler, H T ^c   Posner, J B ^a   DeAngelis, Lisa M ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; BREATHING MUSCLE; CANCER PATIENT; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; DYSPNEA; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; PRIORITY JOURNAL;

EID: 0030975554     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.5.1234     Document Type: Article

References (22)

1. Posner JB. Neurologic complications of cancer. Philadelphia: F. A. Davis, 1995.
2. Gilbert RW, Kim J-H, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978;3:40-51.
3. Nelson SR, Dick AR. Steroids in the treatment of brain edema. In: Azarnoff L, ed. Steroid therapy. Philadelphia: WB Saunders, 1975:313-324.
4. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations. Johns Hopkins Med J 1932;50: 137-195.
5. Muller R, Kugelberg E. Myopathy in Cushings syndrome. J Neurol Neurosurg Psychiatry 1959;27:314.
6. Dekhuijzen PNR, Decramer M. Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. Eur Respir J 1992;5:997-1003.
7. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99:696-701.
8. Gallagher CG. Respiratory steroid myopathy. Am J Crit Care 1994;150:4-6.
9. Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol 1985;76:234-242.
10. Weiner P, Azgad Y, Weiner M. The effect of corticosteroids on inspiratory muscle performance in humans. Chest 1993;104: 1788-1791.
11. Decramer M, Ludovic ML, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994;150:11-16.
12. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977;2:615.
13. Al-Lozi MT, Pestronk A, Yee WC, Flaris N, Cooper J. Rapidly evolving myopathy with myosin-deficient muscle fibers. Ann Neurol 1994;35:273-279.
14. Dropcho EJ, Soong S-J. Steroid-induced weakness in patients with primary brain tumors. Neurology 1991;41:1235-1239.
15. Weissman DE, Dufer D, Vogel V, Abeloff MD. Corticosteroid toxicity in neurooncology patients. J Neurooncol 1987;5:125-128.
16. Vick NA. Letter to the editor. J Neurooncol 1988;6:199.
17. Marshall LF, King J, Langfitt TW. The complications of high-dose corticosteroid therapy in neurosurgical patients: a prospective study. Ann Neurol 1977;1:201-203.
18. Janssens S, Decramer M. Corticosteroid-induced myopathy involving respiratory muscles. Report of two cases. Chest 1989;95:1160-1162.
19. Dubois EL. Triamcinolone in the treatment of systemic lupus erythematosus. JAMA 1958;167:1590-1599.
20. Askari A, Vignos PJ, Moskowitz RW. Steroid myopathy in connective tissue disease. Am J Med 1976;61:485-492.
21. Chromiak JA, Vandenburgh HH. Glucocorticoid-induced skeletal muscle atrophy in vitro is attenuated by mechanical stimulation. Am J Physiol 1992;262(Cell Physiol 31):C1471-C1477.
22. Horber FF, Scheidegger JR, Grunig BE, Frey FJ. Thigh muscle mass and function in patients treated with glucocorticoids. Eur J Clin Invest 1985;15:302-307.